Antares Pharma Inc (ATRS) - Comprehensive Stock Analysis & Investment Research
Deep dive into Antares Pharma Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Antares Pharma Inc, including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Antares Pharma Inc: Antares Pharma Inc operates in the Manufacturing sector, making it an emerging small-cap investment.
Antares Pharma Inc (Stock Symbol: ATRS) is a leading company in the Manufacturing sector , specifically operating within the Surgical and Medical Instrument Manufacturing industry.
The organization employs approximately 185 professionals worldwide and operates under the strategic leadership of CEO Robert Apple.
The company has established itself as an emerging investment opportunity with substantial growth potential.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Antares Pharma Inc's revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Antares Pharma Inc: With $184M in annual revenue and 25.2% net margin, the company demonstrates exceptional profitability.
Annual Revenue: $184 million generating a 25.2% net profit margin .
Market Capitalization: $978 million - Classified as a small-cap investment offering high growth potential.
Return on Equity (ROE): 31.4% - Exceptional shareholder return efficiency, indicating strong management effectiveness.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Antares Pharma Inc stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.
For Antares Pharma Inc: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Antares Pharma Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Antares Pharma Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Antares Pharma Inc: Strong free cash flow generation demonstrates developing operational efficiency.
Antares Pharma Inc strategically competes in the highly dynamic Surgical and Medical Instrument Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .
The company demonstrates robust operational efficiency through strong free cash flow generation of $16 million annually.
The company maintains a healthy 62.9% gross margin, indicating strong pricing power and operational efficiency.